Hilma Biocare Tirzepatide pre-filled pen 10 mg

Hilma Biocare Tirzepatide 10 mg — Weight loss & metabolic control

Tirzepatide is a dual GIP/GLP-1 receptor agonist designed to promote weight loss and improve blood sugar control (similar to Mounjaro/Zepbound).

What it does

Tirzepatide enhances insulin release, suppresses glucagon, reduces appetite, and increases feelings of fullness—driving weight loss and improving metabolic markers.

How to use it

• Dosing schedule: Start at 2.5 mg weekly, increase by 2.5 mg every 4 weeks
• Target dose: 5-15 mg weekly as tolerated
• Administration: Subcutaneous injection once weekly

Important notes

Not for use in pregnancy or breastfeeding. Monitor for GI side effects. Consult with a healthcare professional before use.